ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377 | +13.9% | 14,739 | +27.7% | 0.00% | 0.0% |
| Q2 2023 | $331 | +32.4% | 11,539 | +10.5% | 0.00% | 0.0% |
| Q1 2023 | $250 | +46.2% | 10,439 | +2.9% | 0.00% | – |
| Q4 2022 | $171 | -99.9% | 10,140 | 0.0% | 0.00% | – |
| Q3 2022 | $150,000 | -10.7% | 10,140 | -5.5% | 0.00% | – |
| Q2 2022 | $168,000 | -41.9% | 10,727 | -0.2% | 0.00% | -100.0% |
| Q1 2022 | $289,000 | -30.0% | 10,752 | -3.8% | 0.00% | 0.0% |
| Q4 2021 | $413,000 | -21.0% | 11,172 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $523,000 | +33.4% | 10,954 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $392,000 | -3.4% | 11,607 | +17.8% | 0.00% | 0.0% |
| Q1 2021 | $406,000 | +5.5% | 9,849 | +11.0% | 0.00% | 0.0% |
| Q4 2020 | $385,000 | +66.7% | 8,875 | +64.5% | 0.00% | 0.0% |
| Q3 2020 | $231,000 | +11.1% | 5,396 | +21.0% | 0.00% | 0.0% |
| Q2 2020 | $208,000 | – | 4,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |